| Date Filed | Type | Description |
| 10/06/2023 |
4
| Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Acquired 40,763 shares
@ $0 |
|
| 08/21/2023 |
4
| Labrucherie Gil M (CFO) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Granted 254,939 options to buy
@ $26.94, valued at
$6.9M
|
|
| 08/03/2023 |
3
| Labrucherie Gil M (Interim CFO) has filed a Form 3 on ACELYRIN, Inc. |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 7,579 shares
@ $10.95, valued at
$83k
|
|
| 12/20/2021 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 52,950 shares
@ $0
Granted 94,000 options
@ $13.22, valued at
$1.2M
|
|
| 12/20/2021 |
4/A
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS |
| 11/18/2021 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 21,149 shares
@ $13.16, valued at
$278.3k
Sold 3,000 shares
@ $12.69, valued at
$38.1k
|
|
| 11/17/2021 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,150 shares
@ $0 |
|
| 10/14/2021 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 71,550 options to buy
@ $21.79, valued at
$1.6M
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,000 shares
@ $0
Granted 71,500 options
@ $18.75, valued at
$1.3M
|
|
| 11/18/2020 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 8,276 shares
@ $16.93, valued at
$140.1k
|
|
| 09/21/2020 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,000 shares
@ $19.96, valued at
$39.9k
|
|
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 5,727 shares
@ $22.51, valued at
$128.9k
Sold 2,000 shares
@ $22.62, valued at
$45.2k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,150 shares
@ $0
Granted 71,550 options
@ $21.79, valued at
$1.6M
Granted 29,000 options
@ $21.79, valued at
$631.9k
|
|
| 11/27/2019 |
3
| Labrucherie Gil M (Director) has filed a Form 3 on Rezolute, Inc. |
| 11/20/2019 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 8,863 shares
@ $17.97, valued at
$159.3k
|
|
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
4
| Labrucherie Gil M (SVP, COO & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 25,000 shares
@ $15.83, valued at
$395.8k
Exercised 25,000 options to buy
@ $7.21, valued at
$180.3k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2019 |
4
| Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 25,000 shares
@ $20.52, valued at
$513k
Exercised 25,000 options to buy
@ $7.21, valued at
$180.3k
|
|
| 08/27/2019 |
4
| Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Exercised 30,000 options
@ $16.31, valued at
$489.3k
|
|
| 08/19/2019 |
4
| Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 5,063 shares
@ $18.15, valued at
$91.9k
|
|
| 08/16/2019 |
4
| Labrucherie Gil M (SVP & CFO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 25,000 shares
@ $17.79, valued at
$444.8k
Exercised 25,000 options to buy
@ $7.21, valued at
$180.3k
|
|
|